ERBB2 and breast cancer: Ahmed, ARH and his colleagues23 showed that HER-2 expression in pT1 and pT2 tumors elevated the risk of ALN metastasis by 7.7-fold and 7.6-fold, showed that HER-2 status expression is a strong independent predictor of nodal metastasis in breast cancer.